Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

White vitreous opacities in five patients with Gaucher disease type 3.

Seehra GK, Eghbali A, Sidransky E, FitzGibbon E.

Am J Med Genet A. 2020 Jan 3. doi: 10.1002/ajmg.a.61479. [Epub ahead of print]

PMID:
31898869
2.

Evidence From Parkinson's Disease That the Superior Colliculus Couples Action and Perception.

Pretegiani E, Vanegas-Arroyave N, FitzGibbon EJ, Hallett M, Optican LM.

Mov Disord. 2019 Nov;34(11):1680-1689. doi: 10.1002/mds.27861. Epub 2019 Oct 21.

PMID:
31633242
3.

Acute Care Utilization and Place of Death among Patients Discharged from an Inpatient Palliative Care Unit.

Webber C, Hsu AT, Tanuseputro P, Fitzgibbon E, Li C.

J Palliat Med. 2020 Jan;23(1):54-59. doi: 10.1089/jpm.2019.0162. Epub 2019 Jul 15.

PMID:
31305204
4.

Motion and binocular disparity processing: Two sides of two different coins.

Quaia C, FitzGibbon EJ, Optican LM, Cumming BG.

Prog Brain Res. 2019;248:157-166. doi: 10.1016/bs.pbr.2019.04.026. Epub 2019 May 21.

PMID:
31239128
5.

Ophthalmological findings in Gaucher disease.

Eghbali A, Hassan S, Seehra G, FitzGibbon E, Sidransky E.

Mol Genet Metab. 2019 May;127(1):23-27. doi: 10.1016/j.ymgme.2019.02.002. Epub 2019 Feb 15. Review.

PMID:
31047801
6.

Binocular Summation for Reflexive Eye Movements: A Potential Diagnostic Tool for Stereodeficiencies.

Quaia C, FitzGibbon EJ, Optican LM, Cumming BG.

Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5816-5822. doi: 10.1167/iovs.18-24520.

7.

Advance care planning after hospital discharge: qualitative analysis of facilitators and barriers from patient interviews.

Peck V, Valiani S, Tanuseputro P, Mulpuru S, Kyeremanteng K, Fitzgibbon E, Forster A, Kobewka D.

BMC Palliat Care. 2018 Dec 5;17(1):127. doi: 10.1186/s12904-018-0379-0.

8.

Letter to the Editor Regarding "Optical Coherence Tomography in the Management of Skull Base Fibrous Dysplasia with Optic Nerve Involvement".

Pan KS, FitzGibbon EJ, Lee JS, Collins MT, Boyce AM.

World Neurosurg. 2018 Jun;114:427-428. doi: 10.1016/j.wneu.2018.02.166. No abstract available.

PMID:
29791994
9.

Neurologic syndrome associated with homozygous mutation at MAG sialic acid binding site.

Roda RH, FitzGibbon EJ, Boucekkine H, Schindler AB, Blackstone C.

Ann Clin Transl Neurol. 2016 Jun 23;3(8):650-4. doi: 10.1002/acn3.329. eCollection 2016 Aug.

10.

Human short-latency ocular vergence responses produced by interocular velocity differences.

Sheliga BM, Quaia C, FitzGibbon EJ, Cumming BG.

J Vis. 2016 Aug 1;16(10):11. doi: 10.1167/16.10.11.

11.

Ocular-following responses to white noise stimuli in humans reveal a novel nonlinearity that results from temporal sampling.

Sheliga BM, Quaia C, FitzGibbon EJ, Cumming BG.

J Vis. 2016;16(1):8. doi: 10.1167/16.1.8.

12.

Anisotropy in spatial summation properties of human Ocular-Following Response (OFR).

Sheliga BM, Quaia C, FitzGibbon EJ, Cumming BG.

Vision Res. 2015 Apr;109(Pt A):11-9. doi: 10.1016/j.visres.2015.02.015. Epub 2015 Mar 2.

13.

Action and perception are temporally coupled by a common mechanism that leads to a timing misperception.

Pretegiani E, Astefanoaei C, Daye PM, FitzGibbon EJ, Creanga DE, Rufa A, Optican LM.

J Neurosci. 2015 Jan 28;35(4):1493-504. doi: 10.1523/JNEUROSCI.2054-14.2015.

14.

The role of palliative chemotherapy in hospitalized patients.

Wheatley-Price P, Ali M, Balchin K, Spencer J, Fitzgibbon E, Cripps C.

Curr Oncol. 2014 Aug;21(4):187-92. doi: 10.3747/co.21.1989.

15.

Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11.

Renvoisé B, Chang J, Singh R, Yonekawa S, FitzGibbon EJ, Mankodi A, Vanderver A, Schindler A, Toro C, Gahl WA, Mahuran DJ, Blackstone C, Pierson TM.

Ann Clin Transl Neurol. 2014 Jun 1;1(6):379-389.

16.

Retinal visual processing constrains human ocular following response.

Sheliga BM, Quaia C, FitzGibbon EJ, Cumming BG.

Vision Res. 2013 Dec 18;93:29-42. doi: 10.1016/j.visres.2013.10.002. Epub 2013 Oct 11.

17.

Corollary discharge contributes to perceived eye location in monkeys.

Joiner WM, Cavanaugh J, FitzGibbon EJ, Wurtz RH.

J Neurophysiol. 2013 Nov;110(10):2402-13. doi: 10.1152/jn.00362.2013. Epub 2013 Aug 28.

18.

Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas.

Avery RA, Dombi E, Hutcheson KA, Acosta MT, Baldwin AM, Madigan WP, Gillespie A, Fitzgibbon EJ, Packer RJ, Widemann BC.

Am J Ophthalmol. 2013 Jun;155(6):1089-1094.e1. doi: 10.1016/j.ajo.2013.01.011. Epub 2013 Feb 26.

PMID:
23453281
19.

Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess.

Boyce AM, Glover M, Kelly MH, Brillante BA, Butman JA, Fitzgibbon EJ, Brewer CC, Zalewski CK, Cutler Peck CM, Kim HJ, Collins MT.

J Clin Endocrinol Metab. 2013 Jan;98(1):E126-34. doi: 10.1210/jc.2012-2111. Epub 2012 Oct 23.

20.

Spatial summation properties of the human ocular following response (OFR): dependence upon the spatial frequency of the stimulus.

Sheliga BM, Quaia C, Cumming BG, Fitzgibbon EJ.

Vision Res. 2012 Sep 1;68:1-13. doi: 10.1016/j.visres.2012.07.006. Epub 2012 Jul 20.

21.

Clinical guidelines for the management of craniofacial fibrous dysplasia.

Lee JS, FitzGibbon EJ, Chen YR, Kim HJ, Lustig LR, Akintoye SO, Collins MT, Kaban LB.

Orphanet J Rare Dis. 2012 May 24;7 Suppl 1:S2. doi: 10.1186/1750-1172-7-S1-S2. Epub 2012 May 24.

22.

Ocular following in humans: spatial properties.

Quaia C, Sheliga BM, Fitzgibbon EJ, Optican LM.

J Vis. 2012 Apr 20;12(4). pii: 13. doi: 10.1167/12.4.13.

23.

Surgery versus watchful waiting in patients with craniofacial fibrous dysplasia--a meta-analysis.

Amit M, Collins MT, FitzGibbon EJ, Butman JA, Fliss DM, Gil Z.

PLoS One. 2011;6(9):e25179. doi: 10.1371/journal.pone.0025179. Epub 2011 Sep 23.

24.

The saccadic and neurological deficits in type 3 Gaucher disease.

Benko W, Ries M, Wiggs EA, Brady RO, Schiffmann R, Fitzgibbon EJ.

PLoS One. 2011;6(7):e22410. doi: 10.1371/journal.pone.0022410. Epub 2011 Jul 20.

25.

OrbitView: Eye movement visualization software.

Hong S, Optican LM, Fitzgibbon EJ, Zee DS, Shaikh AG.

J Neurosci Methods. 2011 Sep 15;200(2):181-4. doi: 10.1016/j.jneumeth.2011.06.002. Epub 2011 Jun 13.

26.

Eye movement sequence generation in humans: Motor or goal updating?

Quaia C, Joiner WM, Fitzgibbon EJ, Optican LM, Smith MA.

J Vis. 2010 Dec 29;10(14). pii: 28. doi: 10.1167/10.14.28.

27.

Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate.

Newton-Bishop JA, Chang YM, Elliott F, Chan M, Leake S, Karpavicius B, Haynes S, Fitzgibbon E, Kukalizch K, Randerson-Moor J, Elder DE, Bishop DT, Barrett JH.

Eur J Cancer. 2011 Mar;47(5):732-41. doi: 10.1016/j.ejca.2010.10.008.

28.

A monozygotic twin pair with highly discordant Gaucher phenotypes.

Biegstraaten M, van Schaik IN, Aerts JM, Langeveld M, Mannens MM, Bour LJ, Sidransky E, Tayebi N, Fitzgibbon E, Hollak CE.

Blood Cells Mol Dis. 2011 Jan 15;46(1):39-41. doi: 10.1016/j.bcmd.2010.10.007. Epub 2010 Nov 5.

29.

Fear of pain in patients with advanced cancer or in patients with chronic noncancer pain.

Lemay K, Wilson KG, Buenger U, Jarvis V, Fitzgibbon E, Bhimji K, Dobkin PL.

Clin J Pain. 2011 Feb;27(2):116-24. doi: 10.1097/AJP.0b013e3181f3f667.

PMID:
20890182
30.

Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.

Newton-Bishop JA, Chang YM, Iles MM, Taylor JC, Bakker B, Chan M, Leake S, Karpavicius B, Haynes S, Fitzgibbon E, Elliott F, Kanetsky PA, Harland M, Barrett JH, Bishop DT.

Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):2043-54. doi: 10.1158/1055-9965.EPI-10-0233. Epub 2010 Jul 20. Erratum in: Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1049.

31.

Absent optic chiasm presenting with horizontal nystagmus.

Salchow DJ, Kohlhase J, Miller M, Kadom N, FitzGibbon EJ, Caruso RC, Brooks BP.

J Pediatr Ophthalmol Strabismus. 2010 May-Jun;47(3):187-91. doi: 10.3928/01913913-20090818-08. Epub 2010 May 20.

PMID:
20507004
32.

Amplitudes and directions of individual saccades can be adjusted by corollary discharge.

Joiner WM, Fitzgibbon EJ, Wurtz RH.

J Vis. 2010 Feb 23;10(2):22.1-12. doi: 10.1167/10.2.22.

33.

Knowledge and utilization of palliative radiotherapy by pediatric oncologists.

Tucker TL, Samant RS, Fitzgibbon EJ.

Curr Oncol. 2010 Feb;17(1):48-55.

34.

The initial torsional Ocular Following Response (tOFR) in humans: a response to the total motion energy in the stimulus?

Sheliga BM, Fitzgibbon EJ, Miles FA.

J Vis. 2009 Nov 9;9(12):2.1-38. doi: 10.1167/9.12.2.

35.

Randomized, controlled trial of miglustat in Gaucher's disease type 3.

Schiffmann R, Fitzgibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik IN, Benko W, Timmons M, Ries M, Vellodi A.

Ann Neurol. 2008 Nov;64(5):514-22. doi: 10.1002/ana.21491.

36.

Human ocular following: evidence that responses to large-field stimuli are limited by local and global inhibitory influences.

Sheliga BM, FitzGibbon EJ, Miles FA.

Prog Brain Res. 2008;171:237-43. doi: 10.1016/S0079-6123(08)00633-X.

37.

Spatial summation properties of the human ocular following response (OFR): evidence for nonlinearities due to local and global inhibitory interactions.

Sheliga BM, Fitzgibbon EJ, Miles FA.

Vision Res. 2008 Aug;48(17):1758-76. doi: 10.1016/j.visres.2008.05.017. Epub 2008 Jul 7.

38.

The vergence eye movements induced by radial optic flow: some fundamental properties of the underlying local-motion detectors.

Kodaka Y, Sheliga BM, FitzGibbon EJ, Miles FA.

Vision Res. 2007 Sep;47(20):2637-60. Epub 2007 Aug 15.

39.
40.

Barriers to palliative radiotherapy referral: a Canadian perspective.

Samant RS, Fitzgibbon E, Meng J, Graham ID.

Acta Oncol. 2007;46(5):659-63.

PMID:
17562442
41.

Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation.

Cutler CM, Lee JS, Butman JA, FitzGibbon EJ, Kelly MH, Brillante BA, Feuillan P, Robey PG, DuFresne CR, Collins MT.

Neurosurgery. 2006 Nov;59(5):1011-7; discussion 1017-8.

PMID:
17143235
42.

Human vergence eye movements initiated by competing disparities: evidence for a winner-take-all mechanism.

Sheliga BM, FitzGibbon EJ, Miles FA.

Vision Res. 2007 Feb;47(4):479-500. Epub 2006 Nov 21.

43.

Short-latency disparity vergence eye movements: a response to disparity energy.

Sheliga BM, FitzGibbon EJ, Miles FA.

Vision Res. 2006 Oct;46(21):3723-40. Epub 2006 Jun 12.

44.

Contrast sensitivity, first-order motion and Initial ocular following in demyelinating optic neuropathy.

Rucker JC, Sheliga BM, Fitzgibbon EJ, Miles FA, Leigh RJ.

J Neurol. 2006 Sep;253(9):1203-9. Epub 2006 Apr 28.

45.

Human ocular following initiated by competing image motions: evidence for a winner-take-all mechanism.

Sheliga BM, Kodaka Y, FitzGibbon EJ, Miles FA.

Vision Res. 2006 Jun;46(13):2041-60. Epub 2006 Feb 20.

46.

Family physicians' perspectives regarding palliative radiotherapy.

Samant RS, Fitzgibbon E, Meng J, Graham ID.

Radiother Oncol. 2006 Jan;78(1):101-6. Epub 2005 Dec 5.

PMID:
16330118
47.

The initial ocular following responses elicited by apparent-motion stimuli: reversal by inter-stimulus intervals.

Sheliga BM, Chen KJ, FitzGibbon EJ, Miles FA.

Vision Res. 2006 Mar;46(6-7):979-92. Epub 2005 Oct 18.

48.

Eye movement abnormalities in hermansky-pudlak syndrome.

Gradstein L, FitzGibbon EJ, Tsilou ET, Rubin BI, Huizing M, Gahl WA.

J AAPOS. 2005 Aug;9(4):369-78.

PMID:
16102489
49.

Idiopathic intracranial hypertension following kidney transplantation: a case report and review of the literature.

Chamberlain CE, Fitzgibbon E, Wassermann EM, Butman JA, Kettl D, Hale D, Kirk AD, Mannon RB.

Pediatr Transplant. 2005 Aug;9(4):545-50. Review.

PMID:
16048612
50.

Eye movements in chorea-acanthocytosis.

Gradstein L, Danek A, Grafman J, Fitzgibbon EJ.

Invest Ophthalmol Vis Sci. 2005 Jun;46(6):1979-87.

PMID:
15914612

Supplemental Content

Loading ...
Support Center